Cutaneo-pericardial fistula after transapical aortic valve implantation

Interact Cardiovasc Thorac Surg. 2013 Apr;16(4):558-9. doi: 10.1093/icvts/ivs511. Epub 2012 Dec 17.

Abstract

Transcatheter aortic valve implantation (TAVI) represents a therapeutic option of increasing impact for the treatment of high-risk patients with symptomatic, severe aortic valve stenosis. We report here the case of an 86-year old patient with a cutaneo-pericardial fistula after a transapical TAVI procedure.

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Aortic Valve Stenosis / therapy*
  • Cardiac Catheterization / adverse effects*
  • Cardiac Surgical Procedures
  • Cutaneous Fistula / diagnostic imaging
  • Cutaneous Fistula / etiology*
  • Cutaneous Fistula / microbiology
  • Cutaneous Fistula / therapy
  • Female
  • Heart Diseases / diagnostic imaging
  • Heart Diseases / etiology*
  • Heart Diseases / microbiology
  • Heart Diseases / therapy
  • Heart Valve Prosthesis Implantation / adverse effects*
  • Heart Valve Prosthesis Implantation / methods
  • Humans
  • Pericardium* / diagnostic imaging
  • Pericardium* / microbiology
  • Pericardium* / surgery
  • Proteus Infections / etiology
  • Proteus Infections / microbiology
  • Proteus Infections / therapy
  • Proteus mirabilis / isolation & purification
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Wound Infection / etiology*
  • Wound Infection / microbiology
  • Wound Infection / therapy

Substances

  • Anti-Bacterial Agents